Mallinckrodt lands oral oxycodone, acetaminophen patent; U. of Illinois-Chicago researchers develop nanoscale targeted anti-inflammatory drugs;

> Mallinckrodt ($MNK) collected a patent for its extended-release oral oxycodone and acetaminophen for twice-daily dosing to treat acute pain. It makes use of Depomed's Acuform delivery tech. Release

> Researchers at the University of Illinois at Chicago have developed nanoparticles that target rogue immune cells with anti-inflammatory drugs, while leaving healthy immune cells unharmed. Release

> W.L. Gore touted successful results from its Revise clinical study for its Viabahn Endoprosthesis with Haparin Bioactive Surface. The study showed that it worked better than a percutaneous transluminal angioplasty to treat stenoses or thrombotic occlusions. Release